First Commonwealth Financial Corp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,269
| Closed | -$210K | – | 224 |
|
|
2024
Q4 | $210K | Buy |
+2,269
| New | +$204K | 0.05% | 210 |
|
|
2024
Q2 | – | Sell |
-2,826
| Closed | -$207K | – | 202 |
|
|
2024
Q1 | $207K | Sell |
2,826
-97
| -3% | -$7.46K | 0.05% | 193 |
|
|
2023
Q4 | $237K | Sell |
2,923
-201
| -6% | -$15.6K | 0.07% | 157 |
|
|
2023
Q3 | $234K | Sell |
3,124
-1
| -0% | -$77 | 0.08% | 158 |
|
|
2023
Q2 | $241K | Buy |
3,125
+389
| +14% | +$31K | 0.08% | 158 |
|
|
2023
Q1 | $227K | Hold |
2,736
| – | – | 0.08% | 163 |
|
|
2022
Q4 | $235K | Buy |
+2,736
| New | +$217K | 0.09% | 163 |
|
|
2022
Q1 | – | Sell |
-3,712
| Closed | -$269K | – | 182 |
|
|
2021
Q4 | $269K | Sell |
3,712
-110
| -3% | -$7.58K | 0.09% | 158 |
|
|
2021
Q3 | $267K | Sell |
3,822
-400
| -9% | -$28.1K | 0.1% | 153 |
|
|
2021
Q2 | $291K | Sell |
4,222
-215
| -5% | -$14.4K | 0.1% | 150 |
|
|
2021
Q1 | $286K | Sell |
4,437
-40
| -0.9% | -$2.58K | 0.11% | 144 |
|
|
2020
Q4 | $261K | Hold |
4,477
| – | – | 0.11% | 144 |
|
|
2020
Q3 | $283K | Sell |
4,477
-232
| -5% | -$16.1K | 0.13% | 135 |
|
|
2020
Q2 | $363K | Sell |
4,709
-170
| -3% | -$13K | 0.17% | 109 |
|
|
2020
Q1 | $365K | Sell |
4,879
-139
| -3% | -$9.61K | 0.22% | 90 |
|
|
2019
Q4 | $326K | Sell |
5,018
-300
| -6% | -$19.5K | 0.18% | 104 |
|
|
2019
Q3 | $337K | Sell |
5,318
-590
| -10% | -$38.6K | 0.2% | 98 |
|
|
2019
Q2 | $399K | Sell |
5,908
-700
| -11% | -$46K | 0.24% | 91 |
|
|
2019
Q1 | $430K | Sell |
6,608
-600
| -8% | -$39.9K | 0.27% | 87 |
|
|
2018
Q4 | $451K | Sell |
7,208
-117
| -2% | -$8.18K | 0.32% | 84 |
|
|
2018
Q3 | $566K | Sell |
7,325
-2,320
| -24% | -$175K | 0.38% | 65 |
|
|
2018
Q2 | $683K | Sell |
9,645
-19
| -0.2% | -$1.34K | 0.7% | 41 |
|
|
2018
Q1 | $728K | Sell |
9,664
-661
| -6% | -$52.5K | 0.77% | 38 |
|
|
2017
Q4 | $740K | Sell |
10,325
-2,047
| -17% | -$155K | 0.78% | 35 |
|
|
2017
Q3 | $1M | Sell |
12,372
-1,767
| -12% | -$135K | 1.14% | 26 |
|
|
2017
Q2 | $1M | Sell |
14,139
-162
| -1% | -$10.8K | 1.1% | 29 |
|
|
2017
Q1 | $971K | Sell |
14,301
-3,415
| -19% | -$240K | 1.25% | 30 |
|
|
2016
Q4 | $1.27M | Sell |
17,716
-971
| -5% | -$72.2K | 1.58% | 16 |
|
|
2016
Q3 | $1.48M | Sell |
18,687
-836
| -4% | -$67.9K | 1.93% | 8 |
|
|
2016
Q2 | $1.63M | Sell |
19,523
-197
| -1% | -$17.5K | 2.07% | 7 |
|
|
2016
Q1 | $1.81M | Buy |
19,720
+293
| +2% | +$26.4K | 2.25% | 5 |
|
|
2015
Q4 | $1.97M | Buy |
19,427
+203
| +1% | +$21.1K | 2.33% | 4 |
|
|
2015
Q3 | $1.89M | Sell |
19,224
-324
| -2% | -$36K | 2.36% | 5 |
|
|
2015
Q2 | $2.29M | Sell |
19,548
-1,924
| -9% | -$210K | 2.68% | 3 |
|
|
2015
Q1 | $2.11M | Buy |
21,472
+555
| +3% | +$56.4K | 2.35% | 6 |
|
|
2014
Q4 | $1.97M | Sell |
20,917
-2,677
| -11% | -$277K | 2.13% | 7 |
|
|
2014
Q3 | $2.51M | Sell |
23,594
-1,185
| -5% | -$116K | 2.73% | 5 |
|
|
2014
Q2 | $2.06M | Buy |
24,779
+917
| +4% | +$71.4K | 2.19% | 5 |
|
|
2014
Q1 | $1.69M | Sell |
23,862
-229
| -1% | -$18K | 1.93% | 8 |
|
|
2013
Q4 | $1.81M | Sell |
24,091
-1,626
| -6% | -$113K | 2.03% | 7 |
|
|
2013
Q3 | $1.62M | Sell |
25,717
-1,077
| -4% | -$64.4K | 1.98% | 8 |
|
|
2013
Q2 | $1.37M | Buy |
+26,794
| New | +$1.4M | 1.75% | 13 |
|
Other funds holding GILD
First Commonwealth Financial Corp's GILD Position: Q1 2025 in Review
First Commonwealth Financial Corp sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 2,269 shares — an estimated $210K sold.
First Commonwealth Financial Corp first reported a position in GILD in Q2 2013 and held it in 42 quarters. The position peaked at $2.51M in Q3 2014. 2,012 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- First Commonwealth Financial Corp reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
- First Commonwealth Financial Corp sold 2,269 Gilead Sciences shares in Q1 2025, an estimated $210K.
- First Commonwealth Financial Corp first reported a position in Gilead Sciences in Q2 2013 and held it in 42 quarters.
- First Commonwealth Financial Corp's Gilead Sciences position peaked at $2.51M in Q3 2014.
- 2,012 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on First Commonwealth Financial Corp's 13F filing for Q1 2025, filed 15 May 2025.